Changes in and shortcomings of control strategies, drug stockpiles, and vaccine development during outbreaks of avian influenza A H5N1, H1N1, and H7N9 among humans

BioScience Trends

Volumn 7, Issue 2, 2013, Pages 64-76

  Mei, Lin ^a   Song, Peipei ^b   Tang, Qi ^a   Shan, Ke ^a   Tobe, Ruoyan Gai ^a   Selotlegeng, Lesego ^a   Ali, Asghar Hammad ^a   Cheng, Yangyang ^a   Xu, Lingzhong ^a  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Direct and indirect results; Guidelines; Rapid response stockpile; Timetable

Indexed keywords

INFLUENZA VACCINE;

ANIMAL; AVIAN INFLUENZA; BIRD; EPIDEMIC; HEALTH CARE PLANNING; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A; PHYSIOLOGY; REVIEW; VIROLOGY;

ANIMALS; BIRDS; DISEASE OUTBREAKS; HUMANS; INFLUENZA A VIRUS; INFLUENZA IN BIRDS; INFLUENZA VACCINES; INFLUENZA, HUMAN; STRATEGIC STOCKPILE;

EID: 84880641436     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: 10.5582/bst.2013.v7.2.64     Document Type: Review

References (100)

1. WHO. Cumulative number of confirmed human cases for avian influenza A (H5N1) reported to WHO, 2003-2013. http://www.who.int/influenza/human_animal_interface/EN_GIP_20130312CumulativeNumberH5N1cases.pdf (accessed April 9, 2013).
2. WHO. Epidemiology of WHO-confirmed human cases of avian influenza A (H5N1) infection. Wkly Epidemiol Rec. 2006; 81:249-260.
3. United Nations Statistics Division. The world's women reports. http://unstats.un.org/unsd/demographic/products/indwm/ww2005/tab1b.htm (accessed April 7, 2013).
4. WHO. Avian influenza: Assessing the pandemic threat. http://whqlibdoc.who.int/hq/2005/WHO_CDS_2005.29. pdf (accessed April 7, 2013).
5. Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: A pattern of changing age distribution. J Infect Dis. 1998; 178:53-60.
6. WHO. Guidelines for the use of seasonal influenza vaccine in humans at risk of H5N1 infection. http://www.who.int/influenza/human_animal_interface/virology_laboratories_and_vaccines/vaccine_use_h5N1_ riskgroups/en/ (accessed April 9, 2013).
7. WHO. WHO guidelines for global surveillance of influenza A (H5N1). http://www.who.int/entity/influenza/resources/documents/globalsurveillance.pdf (accessed April 9, 2013).
8. WHO. WHO guidelines for the collection of human specimens for laboratory diagnosis of avian influenza infection. http://www.who.int/influenza/human_animal_interface/virology_laboratories_and_vaccines/guidelines_collection_h5n1_humans/en/index.html (accessed April 9,2013).
9. WHO. WHO laboratory biosafety guidelines for handling specimens suspected of containing avian influenza A virus. http://www.who.int/influenza/resources/documents/guidelines_handling_specimens/en/index.html (accessed April 9, 2013).
10. WHO. WHO guidance on public health measures in countries experiencing their first outbreaks of H5N1 avian influenza. http://www.who.int/influenza/resources/documents/guidance_publichealthmeasures_h5n1_10_2005/en/index.html (accessed April 9, 2013).
11. WHO. WHO rapid advice guidelines on pharmacological management of humans infected with avian influenza A (H5N1). http://www.who.int/medicines/publications/WHO_PSM_PAR_2006.6.pdf (assessed April 9, 2013).
12. WHO. WHO case definitions for human infections with influenza A (H5N1) virus. http://www.who.int/influenza/resources/documents/case_definition2006_08_29/en/index.html (assessed April 9, 2013).
13. WHO. WHO guidelines for investigation of human cases of avian influenza A (H5N1). http://www.who.int/ entity/influenza/resources/documents/WHO_CDS_EPR_ GIP_2006_4r1.pdf (assessed April 9, 2013).
14. WHO. Clinical management of human infection with avian influenza A (H5N1) virus. http://www.who.int/entity/influenza/resources/documents/ClinicalManagement07.pdf (assessed April 9, 2013).
15. WHO. Protection of individuals with high poultry contact in areas affected by avian influenza H5N1: Consolidation of pre-existing guidance. http://www.who.int/influenza/resources/documents/guidance_protection_h5n1_02_2008/en/index.html (assessed April 9, 2013).
16. WHO. WHO guidelines for the storage and transport of human and animal specimens for laboratory diagnosis of suspected avian influenza A infection. http://www.who.int/influenza/resources/documents/transport_storage_specimens/en/index.html (assessed April 9, 2013).
17. WHO. WHO global influenza preparedness plan: the role of WHO and recommendations for national measures before and during pandemics. http://www.who.int/csr/resources/publications/influenza/WHO_CDS_CSR_GIP_2005_5.pdf (assessed April 9, 2013).
18. WHO. Collecting, preserving and shipping specimens for the diagnosis of avian influenza A (H5N1) virus infection. http://www.who.int/entity/csr/resources/publications/surveillance/CDS_EPR_ARO_2006_1.pdf (assessed April 9, 2013).
19. WHO. International health regulations (2005). http://whqlibdoc.who.int/publications/2008/9789241580410_eng.pdf (assessed April 9, 2013).
20. FAO/OIE.WHO. A global strategy for the progressive control of highly pathogenic avian influenza. http://www.oie.int/doc/ged/d2891.pdf (assessed April 7, 2013).
21. WHO. Disease outbreaks by year. http://www.who.int/csr/don/archive/year/en/index.html (assessed April 7 2013).
22. Padhi S, Panigrahi PK, Mahapatra A, Mahapatra S. Avian influenza A (H5N1): A preliminary review. Indian J Med Microbiol. 2004; 22:143-146.
23. WHO. Avian influenza A (H5N1)-update 18: FAO/OIE/WHO technical consultation on the control of avian influenza, situation (human) in Thailand and Viet Nam.http://www.who.int/csr/don/2004_02_05/en/index.html (assessed April 7, 2013).
24. WHO. Disease outbreaks situation in India. http://www.who.int/csr/don/archive/country/ind/en/ (assessed April 8, 2013).
25. Chunsuttiwat S. Response to avian influenza and preparedness for pandemic influenza: Thailand's experience. Respirology. 2008; 13:36-40.
26. The Sate Council of the People's Republic of China. The highly pathogenic avian influenza emergency plan. http://www.gov.cn/xxgk/pub/govpublic/mrlm/200803/t20080328_32348.html (assessed April 9, 2013) (in Chinese).
27. NHFPC of China. Treatment programs of human avian influenza (2005). http://www.moh.gov.cn/mohbgt/pw10509/200804/27436.shtml (assessed April 9, 2013) (inChinese).
28. NHFPC of China. The emergency plan of people infected with highly pathogenic avian influenza. http://www.moh.gov.cn/mohbgt/pw10609/200804/27711.shtml (assessed April 9, 2013) (in Chinese).
29. Homeland Security Council. National strategy for pandemic influenza. http://www.pandemicflu.gov/plan/pdf/CIKRpandemicInfluenzaGuide.pdf (assessed April 7, 2013).
30. U.S. Department of Health and Human Services. Pandemic influenza plan.http://www.flu.gov/planningpreparedness/federal/hhspandemicinfluenzaplan.pdf (assessed April 7, 2013).
31. European Union council. Council directive 2005/94/EC of 20 December 2005 on community measures for the control of avian influenza and repealing directive 92/40/EEC. http://europa.eu/legislation_summaries/other/l12020_en.htm (assessed April 7, 2013).
32. The Writing Committee of the WHO Consultation on Human Influenza A/H5. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005; 353:1374-1385.
33. Buxton Bridges C, Katz JM, Seto WH, et al. Risk of influenza A (H5N1) infection among health care Workers exposed to patients with influenza A (H5N1), Hong Kong. J Infect Dis. 2000; 181:344-348.
34. WHO. Clinical management of human infection with avian influenza A (H5N1) virus. http://www.who.int/entity/influenza/resources/documents/SummaryForm07.pdf(assessed April 7, 2013).
35. WHO. Infection control recommendations for avian influenza in health-care facilities. http://apps.who.int/entity/csr/disease/avian_influenza/guidelines/EPR_AM1_E5.pdf (assessed April 7, 2013).
36. Gaglia MA Jr, Cook RL, Kraemer KL, Rothberg MB. Patient knowledge and attitudes about avian influenza in an internal medicine clinic. Public Health. 2008; 122:462-470.
37. Di Giuseppe G, Abbate R, Albano L, Marinelli P, Angelillo IF. A survey of knowledge, attitudes and practices towards avian influenza in an adult population of Italy. BMC Infect Dis. 2008; 8:36.
38. Leslie T, Billaud J, Mofleh J, Mustafa L, Yingst S. Knowledge, attitudes, and practices regarding avian influenza (H5N1), Afghanistan. Emerg Infect Dis. 2008; 14:1459-1461.
39. Ghabili K, Shoja MM, Kamran P. Avian influenza knowledge among medical students, Iran. Emerg Infect Dis. 2008; 14:672-673.
40. Roche. Roche donates a further 2 million treatment courses of antiviral Tamiflu to the WHO for regional stockpiling. http://www.roche.com/media/media_releases/med-cor-2006-01-17.htm (assessed April 9, 2013).
41. Roche. Rapid response stockpile of Tamiflu now ready and available to the World Health Organisation (WHO). http://www.roche.com/media/media_releases/medcor-2006-04-19.htm (assessed April 9, 2013).
42. NIAID. NIAID announces contracts to develop vaccin against H5N1 avian influenza. http://www.niaid.nih.gov/news/newsreleases/2004/pages/flucontracts.aspx (assessed April 7, 2013).
43. Fauci AS. Pandemic influenza threat and preparedness. Emerg Infect Dis. 2006; 12:73-77.
44. Luke CJ. Subbarao K. Vaccines for pandemic influenza. Emerg Infect Dis. 2006; 12:66-72.
45. Schultz, J. Bird flu vaccine won't precede pandemic. http://www.upi.com/Health_News/2005/11/28/Bird-fluvaccine-wont-precede-pandemic/UPI-94121133218286/(assessed April 7, 2013).
46. Enserink M. Avian influenza. 'Pandemic vaccine' appears to protect only at high doses. Science. 2005; 309:996.
47. Gao W, Soloff AC, Lu X, Montecalvo A, Nguyen DC,Matsuoka Y, Robbins PD, Swayne DE, Donis RO, Katz JM, Barratt-Boyes SM, Gambotto A. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J Virol. 2006; 80:1959-1964.
48. WHO. Antigenic and genetic characteristics of A (H5N1),A (H7N3), A (H9N2) and variant influenza viruses and candidate vaccine viruses developed for potential use in human vaccines. http://www.who.int/entity/influenza/vaccines/virus/201302_h5h7h9_vaccinevirusupdate.pdf(assessed April 9, 2013).
49. WHO. Current WHO phase of pandemic alert (avian influenza H5N1). http://www.who.int/influenza/preparedness/pandemic/h5n1phase/en/index.html(assessed April 9, 2013).
50. US CDC. Update: Novel Influenza A (H1N1) Virus Infections-Worldwide, May 6, 2009. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5817a1.htm (assessed April 10, 2013).
51. Scalera NM, Mossad SB. The first pandemic of the 21st century: A review of the 2009 pandemic variant influenza A (H1N1) virus. Postgrad Med. 2009; 121:43-47.
52. WHO. Disease Outbreak News: Pandemic (H1N1) 2009-update 112. 6 Aug 2010. http://www.who.int/csr/don/2010_08_06/en/index.html (assessed April 10, 2013).
53. WHO. Strategic advisory group of experts on immunization-report of the extraordinary meeting on the influenza A (H1N1) 2009 pandemic, 7 July 2009. Wkly Epidemiol Rec. 2009; 84:301-304.
54. Presanis AM, De Angelis D; New York City Swine Flu Investigation Team, Hagy A, Reed C, Riley S, Cooper BS, Finelli L, Biedrzycki P, Lipsitch M. The severity of pandemic H1N1 influenza in the United States, from April to July 2009: A bayesian analysis. PLoS Med. 2009; 6:e1000207.
55. Hollmann M, Garin O, Galante M, Ferrer M, Dominguez A, Alonso J. Impact of influenza on health-related quality of life among confirmed (H1N1)2009 patients. PLoS One. 2013; 8:e60477.
56. Girard MP, Tam JS, Assossou OM, Kieny MP. The 2009 A (H1N1) influenza virus pandemic: A review. Vaccine. 2010; 28:4895-4902.
57. Bishop JF, Murnane MP, Owen R. Australia's winter with the 2009 pandemic influenza A (H1N1) virus. N Engl J Med. 2009; 361:2591-2594.
58. Libster R, Bugna J, Coviello S, et al. Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med. 2010; 362:45-55.
59. Peiris JS, Poon LL, Guan Y. Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol. 2009; 45:169-173.
60. WHO. Epidemiological summary of pandemic influenza A (H1N1) 2009 virus-Ontario, Canada, June 2009. Wkly Epidemiol Rec. 2009; 84:485-492.
61. WHO. Guidance documents on pandemic (H1N1) 2009: Animal-human interface. http://www.who.int/csr/disease/swineflu/guidance/animal/en/index.html (assessed April 10, 2013).
62. WHO. Guidance documents on pandemic (H1N1) 2009: Clinical care. http://www.who.int/csr/disease/swineflu/guidance/clincal/en/index.html (assessed April 10, 2013).
63. WHO. Guidance documents on pandemic (H1N1) 2009: Healthcare management and facilities. http://www.who.int/csr/disease/swineflu/guidance/healthcare_management/en/index.html (assessed April 10, 2013).
64. WHO. Guidance documents on pandemic (H1N1) 2009: Laboratory and virology. http://www.who.int/csr/disease/swineflu/guidance/laboratory/en/index.html (assessed April 10, 2013).
65. WHO. Guidance documents on pandemic (H1N1) 2009: Pandemic preparedness and response. http://www.who.int/csr/disease/swineflu/guidance/pandemic_preparedness/en/index.html (assessed April 10, 2013).
66. WHO. Guidance documents on pandemic (H1N1) 2009: Surveillance and epidemiology. http://www.who.int/csr/disease/swineflu/guidance/surveillance/en/index.html (assessed April 10, 2013).
67. WHO. WHO recommendations for the post-pandemic period. http://www.who.int/csr/disease/swineflu/notes/briefing_20100810/en/index.html (assessed April 10, 2013)
68. Van Kerkhove MD, Ferguson NM. Epidemic and intervention modelling ? A scientific rationale for policy decisions? Lessons from the 2009 influenza pandemic. Bull World Health Organ. 2012; 90:306-310.
69. Araz OM, Damien P, Paltiel DA, Burke S, van de Geijn B, Galvani A, Meyers LA. Simulating school closure policies for cost effective pandemic decision making. BMC Public Health. 2012; 12:449.
70. Jackson C, Vynnycky E, Hawker J, Olowokure B, Mangtani P. School closures and influenza: Systematic review of epidemiological studies. BMJ Open. 2013;3(2): e002149.
71. WHO. Situation updates ? pandemic (H1N1) 2009. http://www.who.int/csr/disease/swineflu/updates/en/index.html(assessed April 11, 2013).
72. WHO. Weekly virological update on 05 August 2010. http://www.who.int/csr/disease/swineflu/laboratory06_08_2010/en/index.html (assessed April 11, 2013).
73. Editorial. China's health reforms revisited. Lancet. 2010; 375:1053.
74. Wang B, Xie J, Fang P. Is a mass prevention and control program for pandemic (H1N1) 2009 good value for money? Evidence from the chinese experience. Iran J Public Health. 2012; 41:34-43.
75. Rizzo C, Rota MC, Bella A, Giannitelli S, De Santis S, Nacca G, Pompa MG, Vellucci L, Salmaso S, Declich S. Response to the 2009 influenza A (H1N1) pandemic in Italy. Euro Surveill. 2010; 15:pii:19744.
76. Seef S, Jeppsson A. Is it a policy crisis or it is a health crisis? The egyptian context-analysis of the egyptian health policy for the H1N1 flu pandemic control. Pan Afr Med J. 2013; doi:10.11604/pamj.2013.14.59.1631.
77. Mitchell R, Ogunremi T, Astrakianakis G, Bryce E, Gervais R, Gravel D, Johnston L, Leduc S, Roth V, Taylor G, Vearncombe M, Weir C. Impact of the 2009 influenza A (H1N1) pandemic on canadian health care workers: A survey on vaccination, illness, absenteeism, and personal protective equipment. Am J Infect Control. 2012; 40:611-616.
78. Corace K, Prematunge C, McCarthy A, Nair RC, Roth V, Hayes T, Suh KN, Balfour L, Garber G. Predicting influenza vaccination uptake among health care workers: What are the key motivators? Am J Infect Control. 2013; doi:10.1016/j.ajic.2013.01.014.
79. Sharma R, Kaur S, Sodhi A. Knowledge, behaviour change, and anticipated compliance regarding nonpharmaceutical interventions during pandemic of influenza A H1N1 in Delhi. Lung India. 2012; 29:341-346.
80. Tooher R, Collins JE, Street JM, Braunack-Mayer A, Marshall H. Community knowledge, behaviours and attitudes about the 2009 H1N1 Influenza pandemic: A systematic review. Influenza Other Respi Viruses. 2013; doi:10.1111/irv.12103.
81. WHO. Influenza A (H1N1). http://www.who.int/mediacentre/news/statements/2009/h1n1_20090429/en/index.html (assessed April 11, 2013).
82. WHO. World is better prepared for influenza pandemic. http://www.who.int/dg/speeches/2009/asean_influenza_ah1n1_20090508/en/index.html (assessed April 11, 2013).
83. WHO. Status of candidate vaccine virus development for the current Influenza A(H1N1) virus. http://www.who.int/csr/resources/publications/swineflu/vaccine_virus_development/en/index.html (assessed April 11, 2013).
84. Stone R. Swine flu outbreak. China first to vaccinate against novel H1N1 virus. Science. 2009; 325:1482-1483.
85. NHFPC of China. 3 confirmed cases of human infection of H7N9 avian influenza. http://www.moh.gov.cn/mohwsyjbgs/s3578/201303/44f25bd6bed14cf082512d8b6258fb3d.shtml (assessed April 12, 2013) (in Chinese).
86. WHO. Human infection with influenza A (H7N9) virus in China ? update. http://www.who.int/csr/don/2013_04_11/en/index.html (assessed April 12, 2013).
87. NHFPC of China. The information of human infection of H7N9 avian influenza at 11 April. http://www.moh.gov.cn/mohwsyjbgs/s3578/201304/b122d5a6856e4bb89545ad33615a8800.shtml (assessed April 12, 2013) (in Chinese).
88. WHO. Background and summary of human infection with influenza A (H7N9) virus- As of 5 April 2013. http://www.who.int/influenza/human_animal_interface/update_20130405/en/index.html (assessed April 12, 2013).
89. WHO. Real-time RT-PCR protocol for the detection of A (H7N9) influenza virus. http://www.who.int/influenza/gisrs_laboratory/cnic_realtime_rt_pcr_protocol_a_h7n9.pdf (assessed April 12, 2013).
90. NHFPC of China. The notice on strengthening the prevention and control work of human infection H7N9 avian influenza. http://www.moh.gov.cn/mohwsyjbgs/s3582/201304/392e2a1055c84436945f255f13021717.shtml (assessed April 12, 2013) (in Chinese).
91. NHFPC of China. The diagnosis and treatment scheme of human infection with H7N9 avian influenza (Version1, 2013). http://www.moh.gov.cn/ewebeditor/uploadfile/2013/04/20130403184130605.doc (assessed April 12,2013) (in Chinese).
92. NHFPC of China. The guideline of prevention and control of human infection with H7N9 avian influenza in hospital (2013). http://www.moh.gov.cn/ewebeditor/uploadfile/2013/04/20130403184606651.doc (assessed April 12,2013) (in Chinese).
93. NHFPC of China. The diagnosis and treatment scheme of human infection with H7N9 avian influenza (Version2, 2013). http://www.moh.gov.cn/ewebeditor/uploadfile/2013/04/20130410212136993.doc (assessed April 12,2013) (in Chinese).
94. NHFPC of China. The diagnostic procedures of human infection with H7N9 avian influenza cases. http://www.moh.gov.cn/ewebeditor/uploadfile/2013/04/20130410211001283.docx (assessed April 12,2013) (in Chinese).
95. CDC of United States. Avian influenza A (H7N9) virus. http://www.cdc.gov/flu/avianflu/h7n9-virus.htm (assessed April 12, 2013).
96. CDC of United States. Human infections with novel influenza A (H7N9) viruses. http://emergency.cdc.gov/HAN/han00344.asp (assessed April 12, 2013).
97. CDC of United States. Interim guidance on case definitions to be used for novel influenza A (H7N9) case investigations in the United States. http://www.cdc.gov/flu/avianflu/h7n9-case-definitions.htm (assessed April12, 2013).
98. CDC of United States. Interim guidance for infection control within healthcare settings when caring for patients with confirmed, probable, or cases under investigation of avian influenza A (H7N9) virus infection. http://www.cdc.gov/flu/avianflu/h7n9-infection-control.htm (assessed April 12, 2013).
99. CFDA. Anti-influenza drug peramivir sodium chloride injection approved. http://www.sfda.gov.cn/WS01/CL0051/79543.html (assessed April 13, 2013) (in Chinese).
100. NHFPC of China. Ministry of science and technology of the People's Republic of China launch a science and technology research for H7N9 avian influenza virus. http://www.moh.gov.cn/mohbgt/wzbd/201304/6489ef372b8a445690d69a5c023cd8a4.shtml (assessed April 12,2013) (in Chinese).